Nova led the gains today after posting strong third quarter results but Teva fell again.
NICE and Tower led he market higher today but Teva fell despite strong Q3 results.
The Israeli pharmaceutical company beat the analysts and has again raised 2024 revenue guidance, this time to $16.1-16.5 billion.
After Donald Trump's victory in the US presidential election the Tel Aviv Stock Exchange (TASE) indices have climbed to new records while the shekel is appreciating.
Energy, defense, and pharmaceuticals stocks, plus cryptocurrencies, are seen as the big gainers.